We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

32 hedge funds and large institutions have $42.7M invested in Global Cord Blood Corporation in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% less funds holding

Funds holding: 3532 (-3)

9% less capital invested

Capital invested by funds: $47.1M → $42.7M (-$4.42M)

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
32
Holders Change
-3
Holders Change %
-8.57%
% of All Funds
0.85%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
8
Reduced
12
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
OTC
26
Opera Trading Capital
France
$29K
JP Morgan Chase
27
JP Morgan Chase
New York
$23K +$23K +3,847 New
Bank of Montreal
28
Bank of Montreal
Ontario, Canada
$6K
Deutsche Bank
29
Deutsche Bank
Germany
$3K -$233K -39,055 -99%
TRCT
30
Tower Research Capital (TRC)
New York
$3K +$1.04K +175 +71%
Creative Planning
31
Creative Planning
Kansas
$2K
QOP
32
Quinn Opportunity Partners
Virginia
-$236K -37,100 Closed
Citadel Advisors
33
Citadel Advisors
Florida
-$135K -21,168 Closed
Nomura Holdings
34
Nomura Holdings
Japan
-$107K -16,800 Closed
JFA
35
JNBA Financial Advisors
Minnesota
-$27K -4,295 Closed
Walleye Trading
36
Walleye Trading
New York
-$24K -3,800 Closed

CO Hedge Fund Activity: Q1 2016 in Review

32 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q1 2016, worth a combined $42.7M — down 9.4% from $47.1M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of CO and 2 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 8 added.

The largest buyer was Credit Suisse, adding an estimated $1.19M. The largest seller was Acadian Asset Management, cutting an estimated $1.68M.

  • 32 institutional investors held Global Cord Blood Corporation (CO) as of Q1 2016, down from 35 in Q4 2015.
  • Funds reported $42.7M of Global Cord Blood Corporation stock for Q1 2016, down 9.4% quarter-over-quarter.
  • 2 funds opened new Global Cord Blood Corporation positions in Q1 2016 and 5 closed out, a net change of -3 holders.
  • The largest Global Cord Blood Corporation buyer in Q1 2016 was Credit Suisse, an estimated $1.19M added.
  • The largest Global Cord Blood Corporation seller in Q1 2016 was Acadian Asset Management, an estimated $1.68M sold.

Based on aggregated 13F filings for Q1 2016.